BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Nicotine

the prototypical agonist at nicotinic cholinergic receptors where it dramatically stimulates neurons and ultimately blocks synaptic transmission. Nicotine is also important medically because of its presence in tobacco smoke.

298+ PubMed studies analyzed · 14 RCTs · Evidence Score: 40.5

Research Domains

Nicotine has been studied across 16 research domains including 🫁 Liver & Detox, 🧠 Focus & Attention, ❤️ Cardiovascular, 🌤️ Mood & Depression, 🧘 Stress & Anxiety. The primary research focus is 🫁 Liver & Detox with 9% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Nicotine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Mecamylamine
13 shared targets
Lobeline
12 shared targets
Arecoline
12 shared targets
Dimethylphenylpiperazinium
11 shared targets
Dihydro-beta-Erythroidine
4 shared targets
mg624
8 shared targets
desnitroimidacloprid
3 shared targets
Ibogaine
4 shared targets
Anabasine
3 shared targets
Ondansetron
7 shared targets
Loading evidence profile...

This evidence profile for Nicotine is generated deterministically from 298 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.